Biogen (BIIB) Tops Q2 EPS by 12c; Cuts FY15 Revenue Growth, EPS Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rises after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 252.80 +3.87 (1.55%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $248.93 | 52 Week High | $333.65 | |||
| Open | $253.54 | 52 Week Low | $223.02 | |||
| Day High | $255.35 | P/E | 32.37 | |||
| Day Low | $246.49 | EPS | $7.81 | |||
| Volume | 639,095 | |||||
